Verhoef LM, den Broeder N, Thurlings, et al. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. EULAR 2019; Madrid: Abstract LB0010.
Pionieren met waardegedreven zorg
jan 2019
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE